AzTrials
AzTrials

Osteoarthritis, KneeNCT06134050

Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy

A study testing Procedure: HTO using PSI aiming at 55% correction and Procedure: HTO using PSI aiming at 62% correction in people with Osteoarthritis, Knee and Knee Pain Chronic, run by Vestre Viken Hospital Trust.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this RCT is to investigate whether high tibial osteotomy using 3D printed patient specific guides aiming at 55% correction is non-inferior to aiming at 62%. Read more about this study

Who is it for?
Ages 20 to 60 years
What is being tested?
Procedure: HTO using PSI aiming at 55% correction and Procedure: HTO using PSI aiming at 62% correction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
No sites listed yet
Study dates
Nov 2023to Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients having accepted and signed the informed consent form before surgery
  • Patients aged 30-60 years
  • Patients with an indication for primary HTO based on anamnestic, clinical and radiological findings leading to the diagnosis of major medial knee compartment overload symptoms
  • Mechanical varus axis of 3-9 deg. (calculated on full length weightbearing X-ray (FLWB))
  • Correctable angular deformity on the tibia only (medial proximal tibial angle (MPTA) + planned correction < 95 deg. Lateral distal femoral angle (LDFA) <92 deg.)
  • Maximal calculated gap height 14 mm
  • Only the first knee will be included if later contralateral HTO

Who cannot join

  • Inflammatory arthritis (Rheumatoid Arthritis, Bechterew arthritis, Psoriatic Arthritis)
  • Patients using Prednisolone perorally
  • Smokers (need to quit preoperatively)
  • Significant overweight (Body Mass Index > 35)
  • Earlier fractures in affected leg with fracture malalignment >5 deg.
  • Extension deficit >10 deg. in the affected knee
Show all 11Show fewer
  • Earlier septic arthritis/osteomyelitis in the affected leg
  • Previous major surgery affecting leg function. Earlier knee arthroscopic procedures like ACL-reconstruction are not excluded
  • Planned combined procedures involving HTO + ACL/PCL-reconstruction, meniscal transplantation or meniscal root fixation is excluded
  • Neurologic disease with symptoms affecting the leg
  • Serious illness or other factors that make communication, follow-up or rehabilitation difficult (e.g. alcohol or drug abuse, psychiatric disease, non-Norwegian speakers).

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Geir Solberg, MD contact

+4746821397

geir.solberg@mhh.no

Tor Kjetil Nerhus, MD,PhD contact

+4793409934

kjetil.nerhus@mhh.no

About this study

Official title: Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy Using 3D Printed Patient-specific Instrumentation (PSI). An RCT Comparing Correction Aimed at 62% Versus 55%.

The purpose of this RCT is to investigate whether high tibial osteotomy using 3D printed patient specific guides aiming at 55% correction is non-inferior to aiming at 62%.

Read the detailed description

HTO should play a major role in modern treatment algorithms for knee overload and osteoarthritis. By transferring load from the failing/osteoarthritic compartment of the knee to a healthier compartment, HTO can delay or stop the progression of osteoarthritis at an early stage. This can remove pain and increase knee function, making return to work, activities and sport possible. HTO may delay or avoid the need for total knee replacement for >10 years for at least 80% of patients.

The optimal target for the postoperative mechanical axis of the leg is not yet clarified. Both under- and overcorrection can lead to unfavourable results. The classical Fusjisawa´s point of 62%, or approximately 3 deg. of valgus, is still often used as the optimal target, and studies show good clinical results and longevity. With an often accepted accuracy of +/- 3 deg. with conventional methods, the accepted postoperative range of valgus will be from 0 deg. to 6 deg. But the optimal range is possibly much narrower. Recent studies suggest a narrower range and less overcorrection.

3D-printed patient specific instrumentation (PSI) is based on CT of the individual patient´s knee, data simulation of the planned correction and subsequent 3D printed guides for each patient. The PSI design varies, but involves a positioning guide fitting only in position one the proximal tibia, a cutting guidance and a wedge opening guide. PSI seem to improve accuracy to the level of approximately +/- 1 deg. from the preplanned correction and leads to fewer unacceptable outliers compared to the conventional methods available. Improved accuracy has not shown to yield better clinical results.

In the future the target axis should possibly be individualized, based on the pathology treated, gait analyses and data simulations.

Modern gait analysis using wearable accelerator sensors, often referred to as inertial measurement units (IMUs) is rapidly evolving. By coupling individualized and accurate osteotomy with gait analysis using wearable sensors, one could better predict and understand how to normalise each individual patients´ gait pattern and possibly improve patient satisfaction and function after surgery.

By coupling the highly accurate PSI method, an angular stable implant and a composite of outcomes based on radiology, validated patient reported outcome measures and gait analysis, our RCT can investigate if a correction target of 55% is non-inferior to the common 62%.

The study will be designed as a continuous outcome non-inferiority trial where KOOS QoL subscale is used as the primary outcome and the basis for sample size calculation. The Minimal Clinical Important Difference (MCID) for KOOS QoL regarding HTO is 16.5 points. A presumed standard deviation (SD) of 23 points is obtained from a previous study on a similar population. A one-sided t-test power analysis with 2.5% significance level and 80% power level indicates that 31 patients would be needed in each group. In total 70 patients is planned to be included, which takes into account up to 10% dropout rate and some uncertainty regarding the predicted score values.

Statistics:

The primary outcome will be analyzed with a linear mixed model, where the measurements from all time points will be included. The main effect measure will be the between-group difference in change from baseline to two years, which will be estimated with a 95% confidence interval and a P-value for non-inferiority where the null hypothesis is that osteotomy correction to the 55% target is inferior to the correction to the 62% target and the alternative states that it is not. Inferiority is determined by KOOS QOL difference of at least MCID.

Paired samples t-tests will be used to analyze differences between pre- and postoperative measurements on X-rays within each group. Independent samples t-tests will be used to analyze differences between groups. A p-value < 0.05 is considered statistically significant.

Being tested
Procedure: HTO using PSI aiming at 55% correction, Procedure: HTO using PSI aiming at 62% correction
Keywords
osteotomy, knee, osteoarthritis, 3D print, PSI, High tibial osteotomy, Knee overload, Inertial measurement units, IMU, wearable sensors, gait analysis, accelerometer
Medical subject headings
Osteoarthritis, Knee, Arthralgia, Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Procedure: HTO using PSI aiming at 55% correctionProcedure or surgery

    HTO using PSI designed to achieve correction to 55% tibial width.

  • Procedure: HTO using PSI aiming at 62% correctionProcedure or surgery

    HTO using PSI designed to achieve correction to 62% tibial width.

Study groups in NCT06134050
Study groupRoleWhat they receive
55% correctionExperimentalHTO using PSI targeted at 55% correction axis
Receives: Procedure: Procedure: HTO using PSI aiming at 55% correction
62% correctionActive comparatorHTO using PSI targeted at 62% correction axis
Receives: Procedure: Procedure: HTO using PSI aiming at 62% correction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee injury and Osteoarthritis Outcome Score subscore Quality of Life (KOOS QOL), 0-100, 100 best score

    Knee related Quality of Life

    Measured: 24 months

Secondary outcomes (5)
  1. Knee injury and Osteoarthritis Outcome Score 12 Short form (KOOS-12), 0-100, 100 best score

    Knee related pain, symptoms, ADL, QoL and function

    Measured: 24 months

  2. Forgotten Joint Score-12(FJS-12), 0-100, 100 best score

    Knee related symptoms and function

    Measured: 24 months

  3. EuroQol-5D (EQ-5D), index 0-1, 1 best score

    Health related quality of life

    Measured: 24 months

  4. University of California at Los Angeles activity level (UCLA), 0-10, 10 most active

    Activity level score

    Measured: 24 months

  5. Ground contact time (milliseconds)

    Accelerometer based gait analysis

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2023
  2. Study startNov 2023 (estimated)
  3. Primary completionOct 2026 (estimated)
  4. Study completionOct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06134050
Sponsor's protocol ID
GS001
Status last verified
Nov 2023
First submitted
23 Jun 2023
Last updated
18 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Procedure: HTO using PSI aiming at 55% correction and Procedure: HTO using PSI aiming at 62% correction in people with Osteoarthritis, Knee and Knee Pain Chronic, run by Vestre Viken Hospital Trust.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Geir Solberg, MD (+4746821397, geir.solberg@mhh.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee injury and Osteoarthritis Outcome Score subscore Quality of Life (KOOS QOL), 0-100, 100 best score (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in